-
Intercept, after biotech rollercoaster ride, agrees to buyout by Alfasigma
26 Sep 2023 16:36 GMT
Liver drug developer Intercept Pharmaceuticals has agreed to … Tuesday, ending one of biotechnology’s most noteworthy stories … founder, Alfasigma markets drugs like Zelnorm and rifaximin for irritable … by some trial participants given the drug. Following that …
-
FDA Finally Held Accountable for Illegal Approval of Abortion Drugs
12 Apr 2023 11:54 GMT
… of four medical associations and four doctors.
In 2000, the FDA succumbed to … who use chemical abortion drugs end up needing medical help afterwards. The adverse … restrictions.) Other examples include Pondimin, Zelnorm, Cylert, and Raptiva.
Despite reports …
-
Here’s why we’re not prepared for the next wave of biotech innovation
03 Nov 2022 09:23 GMT
… . The treatment is being developed by two biotechnology companies, Vertex Pharmaceuticals and CRISPR … prove a medicine is truly effective.
The cholesterol drugs known as statins — atorvastatin … trials is so, so difficult.
“My personal thought is that the trial …
-
Alfasigma USA, Inc. Engages Indegene, Inc. to Expand the Promotion of ZELNORM® to Healthcare Professionals in the United States
23 Jul 2020 13:30 GMT
… Constipation (IBS-C) drug, ZELNORM® (tegaserod), to … ZELNORM® was approved for reintroduction by the FDA for the treatment … Safety & Compliance; Medical Affairs; Training & Communication … a leading Italian pharmaceutical company. Alfasigma is …
-
Innovation Pharmaceuticals Provides Update on Clinical Trials and Revenue Potential of Brilacidin in Inflammatory Bowel Diseases
10 Dec 2019 14:30 GMT
… 2020 to commence clinical trials of Brilacidin for UP… new class of medicine for the treatment of IBD.
As … CerefolinNAC®). Alfasigma recently acquired ZELNORM™ for the American market … pharmaceutical company and the anticipated terms thereof, our future drug …
-
Innovation Pharma Makes Savvy Move in Partnering with Alfasigma for New IBD Drug
24 Jul 2019 23:07 GMT
… in gastrointestinal medications, with 22 drugs and drug candidates inits … Alfasigma USAacquiredthe brand ZELNORM, a prescription pharmaceutical treatment for IBS-C, … , a Phase 2 trial of an oral rinse … order to make the pill (or capsule or tablet …
-
Ironwood Pharmaceuticals' (IRWD) CEO Mark Mallon on Q2 2019 Results - Earnings Call Transcript
31 Jul 2019 01:37 GMT
… President
Mike Shetzline – Chief Medical Officer
Conference Call Participants
David … everyone to the Ironwood Pharmaceuticals Second Quarter 2019 Investor … 2b clinical trial of 7246 for the treatment of pain … prucalopride, as well as Zelnorm. I mean, there…
-
US WorldMeds reintroduces Zelnorm (tegaserod) for treating IBS-C in women under 65
02 Apr 2019 09:04 GMT
Pharmaceutical company US WorldMeds revealed on … Drug Administration (FDA) for the relaunch of its twice-daily oral Zelnorm (tegaserod) treatment … 29 placebo-controlled trials and newly-available sources of treatment outcome data …
-
FDA Approves the Reintroduction of Zelnorm (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in Women Under 65
03 Apr 2019 07:53 GMT
… Drug Administration (FDA) for the reintroduction of Zelnorm™ (tegaserod), a twice-daily oral treatment … clinical trials, patients taking Zelnorm saw … Zelnorm. Stop taking Zelnorm and get medical … personal approach to pharmaceuticals – pioneering research …
-
Ironwood Pharmaceuticals Appoints Michael Shetzline, M.D., Ph.D. as Chief Medical Officer
07 Jan 2019 10:12 GMT
…
successful approved drug development programs … franchise team
supporting ZELNORM while at Novartis. … Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD) is a commercial biotechnology
company focused on creating medicines …
Phase IIIb trial evaluating its …